| Name | Title | Contact Details |
|---|
Ovid Therapeutics is a biopharmaceutical company focused exclusively on developing impactful medicines for patients and families living with rare neurological disorders. Ovid`s drug candidate, OV101, is currently in development for the treatment of symptoms of Angelman syndrome and Fragile X syndrome. Ovid is also developing OV935 in collaboration with Takeda Pharmaceutical Company Limited for the treatment of rare epileptic encephalopathies. Ovid has initiated the Phase 2 STARS trial of OV101 in adults with Angelman syndrome and a Phase 1 trial in adolescents with Angelman and Fragile X syndrome to identify doses suitable for younger patients.
Cerami is a Belleville, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
BMEYE - Cardiovascular Intelligence is a Louisville, KY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
South Country Health Alliance is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Owatonna, MN. To find more information about South Country Health Alliance, please visit www.mnscha.org
Edgerton Hospital and Health Services is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Edgerton, WI. To find more information about Edgerton Hospital and Health Services, please visit www.edgertonhospital.com